Alligator held a virtual R&D Day on August 27, in which CEO Per Norlén and COO Malin Carlsson gave an update on the status and latest development steps in the company's clinical pipeline. Guest speaker, Professor Ignacio Melero at University of Navarra, gave his view on 4-1BB, the target for ATOR-1017. Listen to the presentations here.